Statistics
Publications
5
Citations
605
H-Index
5
Active since
2013
Amy Rommel is an author at Salk Institute for Biological Studies specializing in molecular oncology, oncology, and medicine.
Publications per year
2013–2018
5
5
Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence
Gabriele Sulli, Amy Rommel, Xiaojie Wang et al. · Nature · 2018 · 410 citations
Medicine, Cancer Biology, Oncology +11
Dovitinib enhances temozolomide efficacy in glioblastoma cells
Thatchawan Thanasupawat, Suchitra Natarajan, Amy Rommel et al. · Molecular Oncology · 2017 · 29 citations · Full text
Medicine, Cell Biology, Oncology +17
1–5 of 5